Clinical Trial Update: VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1) [Phase 1]

View source ↗

Summary

This clinical trial update discusses the RESTORE-1 Phase 1 study of VY-AADC02 for Parkinson's disease with motor fluctuations, which has completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• VY-AADC02

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED